The review, titled “The Hallmarks of Protein and Amino Acid Restriction in Aging and Longevity,” was authored by Bailey A. Knopf and Dudley W. Lamming of the University of Wisconsin-Madison and published in Cell Press Blue. It examined how reducing protein intake, or specifically reducing certain amino acids, affects aging-related biology across more than 350 studies.

The researchers point to a hormone called FGF21 as a key mechanism behind the eating less protein effect. Protein restriction raises FGF21 levels in both animals and humans, and higher FGF21 has been linked to increased energy expenditure, better blood sugar control, and reduced inflammation. In mouse studies, animals with elevated FGF21 lived longer than normal mice, with the effect more pronounced in males than females. The review also flags three specific amino acids, methionine, isoleucine, and valine, as building blocks that may drive some of these effects when consumed in excess.

This isn’t the first time researchers have looked at protein restriction, but it’s one of the largest attempts to pull the evidence together in one place. Scientists have known for decades that restricting protein extends lifespan in yeast, fruit flies, mice, and rats under controlled lab conditions. What’s changed recently is the intensity of interest in whether the same mechanisms translate to humans, driven partly by the broader boom in longevity research and partly by a growing pile of population-level data that keeps pointing in the same direction.

One of the more striking data points cited in the coverage of this review comes from a 2023 study of roughly 1,500 pairs of British twins over age 60. Because twins share genetics and often much of their environment, comparing siblings within a pair controls for a huge number of variables that mess up typical nutrition studies. The finding: the twin who ate more protein had a higher risk of developing sarcopenia, age-related muscle loss, than their lower-protein sibling.

Lamming has called this result “exactly the opposite” of what conventional wisdom would predict, since protein is usually framed as protective against muscle loss. It doesn’t necessarily contradict every other finding on protein and muscle, but it’s a real, published data point that complicates the simple “more protein equals more muscle” story that dominates fitness marketing and social media advice today.

It’s worth noting this finding sits alongside other research pointing the opposite way. Some studies have shown higher protein diets promote weight loss and lower sarcopenia risk in older adults, particularly when combined with resistance training. That apparent contradiction, higher protein sometimes protecting against muscle loss and sometimes predicting it, is part of what drew Lamming to study this area of aging research in the first place, and it’s a big reason researchers describe this as an emerging picture rather than a settled one.

Beyond animal data, the review cites human clinical trials showing real, measurable effects tied specifically to eating less protein rather than just eating fewer calories overall. One trial found that people following a low-protein diet for 43 days lost body weight and body fat, and had lower fasting blood sugar, despite eating more total calories than before the trial started. That’s a notable detail: the benefit wasn’t just from eating less overall, it tracked specifically with the drop in protein intake itself.

Epidemiological data adds another layer. Lamming has pointed to a series of large population studies showing that people eating higher-protein diets tend to have higher rates of cancer, diabetes, cardiovascular disease, and in some studies, mortality. Those are correlational findings, not proof of direct cause and effect, but they’re consistent enough across multiple large datasets that researchers are taking the pattern seriously.

What makes the 43-day trial notable is the calorie detail. Losing weight and improving blood sugar while eating more calories overall runs against the simple “calories in, calories out” framing most people use to think about weight and metabolism. It suggests the specific macronutrient composition of a diet, not just its total energy content, is doing meaningful metabolic work, which lines up with what the FGF21 research is describing at a hormonal level.

Lamming and other aging researchers have been explicit that this isn’t a green light for everyone to slash protein intake. Older adults face a real risk from sarcopenia, and the research on resistance exercise plus adequate protein helping preserve muscle and strength in that population is well established and shouldn’t be abandoned based on one review. People with kidney disease, liver disease, or other conditions affecting protein metabolism need individualized medical guidance, not general population advice.

Activity level matters enormously here too. As Lamming himself put it, recent guidelines encouraged people to eat more protein, but they also encouraged more exercise, and those two pieces of advice were never meant to be separated. The population most likely to see benefit from eating less protein is sedentary adults already getting more than they need, not competitive athletes, older adults doing strength training, or anyone recovering from illness or surgery.

There’s also a scale problem worth naming directly. Much of the strongest, most consistent evidence for lifespan extension through protein restriction comes from short-lived organisms like yeast and fruit flies, where researchers can run full lifespan studies in weeks or months rather than decades. Human trials on the same question have generally been small and short-term by comparison, simply because studying human aging over decades is logistically difficult and expensive. That gap between animal and human evidence is exactly why researchers are calling for more targeted human trials rather than treating this as a closed case.

The current RDA sits at 0.8 grams per kilogram of body weight per day for sedentary adults, a baseline many nutrition marketers treat as a bare minimum to exceed rather than a legitimate target grounded in actual physiological need. Moderately active adults typically land somewhere around 1.0 to 1.2 g/kg, endurance athletes around 1.2 to 1.4 g/kg, and adults doing serious resistance training often benefit from 1.6 to 2.2 g/kg, particularly older adults working to preserve muscle mass against age-related decline.

The honest takeaway from this review isn’t “eat less protein” as a universal rule. It’s “stop assuming more protein is automatically better regardless of how active you are.” For someone already eating well above their activity level’s needs from protein bars, shakes, and fortified snacks, dialing back toward the RDA baseline may be the evidence-backed move. For someone lifting weights three times a week or recovering from an injury, the opposite is still true.

It also helps to remember why protein marketing got this aggressive in the first place. Protein is genuinely satiating, genuinely useful for muscle repair, and genuinely easy to market as an unambiguous good, unlike, say, fat or carbohydrates, which carry decades of contested and confusing messaging. That made it an easy nutrient to build an entire product category around, from protein water to protein popcorn, largely independent of whether the people actually buying those products needed more of it in the first place.

What this looks like on an actual weeknight for a sedentary adult: swapping a protein-fortified snack out of habit for a normal whole-food option, and not reflexively adding a protein powder scoop to a smoothie that’s already nutritionally complete without it. Neither change requires eliminating protein or overhauling an entire diet overnight.